Search Ontology:
ChEBI
leukotriene B4
- Term ID
- CHEBI:15647
- Synonyms
-
- (5S,12R,6Z,8E,10E,14Z)-5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid
- (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyeicosa-6,8,10,14-tetraenoic acid
- (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid
- (S-(R*,S*-(E,Z,E,Z)))-5,12-Dihydroxy-6,8,10,14-eicosatetraenoic acid
- 5(S),12(R)-dihydroxy-6(Z),8(E),10(E),14(Z)-eicosatetraenoic acid
- 5(S),12(R)-dihydroxy-6(Z),8(E),10(E),14(Z)-icosatetraenoic acid
- 5,12-Dihete
- 5,12-Hete
- 5S,12R-diHETE
- 5S,12R-dihydroxy-6Z,8E,10E,14Z-eicosatetraenoic acid
- Leukotriene B4
- LTB4
- Definition
- A leukotriene composed of (6Z,8E,10E,14Z)-icosatetraenoic acid having (5S)- and (12R)-hydroxy substituents. It is a lipid mediator of inflammation that is generated from arachidonic acid via the 5-lipoxygenase pathway.
- References
-
- cas:71160-24-2
- chemspider:4444132
- drugbank:DB12961
- hmdb:HMDB0001085
- kegg.compound:C02165
- knapsack:C00053425
- lipidmaps:LMFA03020001
- pdb-ccd:LTB
- pubmed:10087000
- pubmed:10391868
- pubmed:10695938
- pubmed:11166796
- pubmed:11254552
- pubmed:12709426
- pubmed:12742837
- pubmed:12947016
- pubmed:1327049
- pubmed:1333134
- pubmed:1335872
- pubmed:1338371
- pubmed:15016629
- pubmed:15515787
- pubmed:16567388
- pubmed:1661709
- pubmed:17481557
- pubmed:17548641
- pubmed:17623009
- pubmed:1847289
- pubmed:20400503
- pubmed:20529300
- pubmed:20671299
- pubmed:23625922
- pubmed:32439596
- pubmed:32960415
- pubmed:33292560
- pubmed:33612149
- pubmed:6271967
- pubmed:7924852
- pubmed:8243477
- pubmed:8382716
- pubmed:8397308
- pubmed:9209678
- pubmed:9516893
- pubmed:9606840
- reaxys:4235309
- wikipedia.en:Leukotriene_B4
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from leukotriene B4
Phenotype where environments contain leukotriene B4
Phenotype modified by environments containing leukotriene B4
Phenotype affecting leukotriene B4
Human Disease Model